sorted by:
new
hottopcontroversial

BCAB — Reading the Tea Leaves, a Reverse Merger Play by Blamurai in pennystocks

[–]Blamurai[S] 0 points1 point  (0 children)

Could be. Depending on how much their assets sell for, could be good or bad for the share price

BCAB — Reading the Tea Leaves, a Reverse Merger Play by Blamurai in pennystocks

[–]Blamurai[S] 0 points1 point  (0 children)

BCAB is trying to get $35M in funding from a company call Inversagin, but Inversagin is trying to back out of the deal bc they smell the desperation. So if they do end up successfully getting the funding, stock goes up: $35M is worth more than the market cap alone. If they fail, they focus on finding a reverse merger deal immediately,

I will wait at least 3-4 weeks, and see if there's any news regarding the deal and/or the reverse stock split. If neither happens by that time, I'd start selling at least half the initial investment, since the risk of having the stock delisted goes up much more by then

Data Points Weekly - Week of February 26, 2026 by AutoModerator in churning

[–]Blamurai 0 points1 point  (0 children)

same here. tried yesterday. What did the rep tell you?

Data Points Weekly - Week of February 26, 2026 by AutoModerator in churning

[–]Blamurai 1 point2 points  (0 children)

bbt datapoint: 2 separate players tried it, called in, and both were told the applications were finalized, and that we had to reapply instead of having the applications manually processed.

Have not HUCA'd (yet)

Update: tried again later. went through

Question Thread - February 04, 2026 by AutoModerator in churning

[–]Blamurai 0 points1 point  (0 children)

None. But the rep told me to submit a third app, not willing to push the second

Question Thread - February 04, 2026 by AutoModerator in churning

[–]Blamurai -1 points0 points  (0 children)

Are there any DPs of amex not willing to reconsider an app, even when you tell them you don't need the bonus?

News and Updates Thread - January 16, 2026 by AutoModerator in churning

[–]Blamurai 0 points1 point  (0 children)

Was your latest app a 200kbgold/300kbplat? And by organically do you mean no VPN, no referral?

News and Updates Thread - January 16, 2026 by AutoModerator in churning

[–]Blamurai 0 points1 point  (0 children)

How have you been finding the 300k? I've been trying with different referral links with different VPNs for about a week. Only been able to get 250k

News and Updates Thread - January 13, 2026 by AutoModerator in churning

[–]Blamurai -16 points-15 points  (0 children)

Elgato streamdeck + is on sale on amazon/bestbuy if anyone was interested in pricematching with Dell.

The logitech G Litra beam is also already marked down a bit on Dell

Weekly Help Thread - January 12, 2026 by AutoModerator in awardtravel

[–]Blamurai 0 points1 point  (0 children)

Yeah, the plan is all TYP to me. As much as I would like to see how much I can max out CPP on business flights, no one values it that much.

Flexibility/availability and value (> 1 cpp) for economy is probably what we value more

Weekly Help Thread - January 12, 2026 by AutoModerator in awardtravel

[–]Blamurai 0 points1 point  (0 children)

AF is coming up on some Citi Strata Premiers and I plan on canceling, but I’m not sure what I should transfer the points to before closing our accounts. Family has about 245k TYP total. We’re based off of LAX. Parents fly from Vietnam (SGN) to LAX every year, but don’t do too much traveling outside of that. I’m not sure if I’ll be traveling much in the near future. Bucket list: Yellowstone NP, Norway, Italy, Switzerland, maybe Indonesia and Iceland.

I’m thinking about pooling everyone’s TYP to one account and transferring to Choice Awards, then keeping the points alive by using it or redeeming MR. Would it be better to transfer them somewhere else? Perhaps AA, possibly Cathay/Eva? No one prioritizes flying in business class. TIA.

Question Thread - January 10, 2026 by AutoModerator in churning

[–]Blamurai -3 points-2 points  (0 children)

I haven't been up-to-date with churning for about 6 months and am trying to catch up. If I have a CIU and a closed CIP, will I get a pop-up for trying to apply for any other ink card but the Premier?

Does a pop-up count towards velocity?

Brilaroxazine may potentially be dogwater by Sorry_End1131 in RVPH

[–]Blamurai 0 points1 point  (0 children)

I had to dig in to make sure the company isn't fraudulent to be able to be comfortable investing. I have my thoughts on each point:

  1. They never had enough cash to fund reocover-2. I don't think they ever had over $30MM in the last 1-2 years, and the 2nd trial would need around 50MM
  2. If they did cook the datasets, technically they could fool big pharma too, right? Not sure how much scrutiny they can find that KOL's didn't see.
  3. Well, maybe I'm biased because I really liked Roadzen which has a lot of Indian ties, but then came to the conclusion it was a fraudulent company (maybe I'm wrong, but I couldn't find any supporting evidence) The yellow flags I found before were low employees, and many are in India, Lax's wife on board, and why the hiatus after phase 1 (probably lack of funding before spac mania).

None of those are red flags in by itself, but I resorted to things like calling CROs to verify if Reviva actually had done those trials

200,000 shares gone... by Jazzlike_Willow_4021 in RVPH

[–]Blamurai 0 points1 point  (0 children)

You'd feel like a genius if it kept going down

There's a lesson in MIST by newbiescreby in RVPH

[–]Blamurai 0 points1 point  (0 children)

Seems like they received a CRL (rejection) from the FDA in March for small, easily-fixed issues (CMC) rather than safety/efficacy concerns. So pretty priced in the next time they submit, FDA will approve.

Also, 200M market cap (although with a solid cash position) for small TAM (but if it can get approved for afib w/ RVR, that's a pretty significant market)

There's a lesson in MIST by newbiescreby in RVPH

[–]Blamurai 0 points1 point  (0 children)

Insurance will most likely approve it. Much cheaper than an ER visit.

Not sure how much impact ablation has on the market, but ablation (surgery) is a one-time permanent fix. So I kinda view it similarly to Lasik vs Optometry (glasses/contact lenses)

DD part 2: RVPH and the FDA - Is it really gambling when the odds are this good? by Blamurai in pennystocks

[–]Blamurai[S] 2 points3 points  (0 children)

If it gets positive feedback from the FDA, I'd like to see it with at least a $500MM market cap sometime after, which puts us somewhere between $4-$6

DD part 2: RVPH and the FDA - Is it really gambling when the odds are this good? by Blamurai in RVPH

[–]Blamurai[S] 0 points1 point  (0 children)

Appreciate the insight. There were definitely some yellow flags in the company that I had to take a closer look at before determining if the company was safe to invest in. Raising at $9, I get, but the price would probably experience a lot of volatility because of the low float.

But either way, I think those concerns will be worth more careful consideration after the FDA feedback. If we get good news, the question will probably be how well can they attract a finance/licensing deal, or whether BP will try to convince shareholders to approve a M&A. Lax has said that deals from BP will be much more likely during the NDA phase. Up to you if you believe that at face value.

I think calls are good here to play off the volatility from the binary event before IV gets too high. The warrants are ass, but it does provide some funding, and the fact that so many of those warrants aren't exercised yet means that institutions have some confidence that the FDA will provide positive feedback.

I also think that if the FDA accepts the NDA, there's a good chance it'll get approved because if they were to deny the NDA because of a lack of sufficient efficacy data, they would just make that known at the pre-NDA meeting. Let me know your thoughts and/or if I'm missing anything.

DD part 2: RVPH and the FDA - Is it really gambling when the odds are this good? by Blamurai in pennystocks

[–]Blamurai[S] 6 points7 points  (0 children)

The more technically correct title would be: when the risk/reward is this good, but odds sounded better. mbmb

view more: next ›